Suzuki E - Search Results

1

Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.

Suzuki E, Umezawa K. Suzuki E, et al. Biomed Pharmacother. 2006 Nov;60(9):578-86. doi: 10.1016/j.biopha.2006.07.089. Epub 2006 Sep 1. Biomed Pharmacother. 2006. PMID: 16978829

2

Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages.

Suzuki E, Sugiyama C, Umezawa K. Suzuki E, et al. Biomed Pharmacother. 2009 Jun;63(5):351-8. doi: 10.1016/j.biopha.2008.05.003. Epub 2008 Jun 20. Biomed Pharmacother. 2009. PMID: 18635336

3

Induction of histidine decarboxylase in macrophages inhibited by the novel NF-kappaB inhibitor (-)-DHMEQ.

Suzuki E, Ninomiya Y, Umezawa K. Suzuki E, et al. Biochem Biophys Res Commun. 2009 Feb 6;379(2):379-83. doi: 10.1016/j.bbrc.2008.12.065. Epub 2008 Dec 25. Biochem Biophys Res Commun. 2009. PMID: 19103154

4

Efficient synthesis of (+/-)-parasitenone, a novel inhibitor of NF-kappaB.

Saitoh T, Suzuki E, Takasugi A, Obata R, Ishikawa Y, Umezawa K, Nishiyama S. Saitoh T, et al. Among authors: suzuki e. Bioorg Med Chem Lett. 2009 Sep 15;19(18):5383-6. doi: 10.1016/j.bmcl.2009.07.120. Epub 2009 Jul 30. Bioorg Med Chem Lett. 2009. PMID: 19666224

5

Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.

Kodaira K, Kikuchi E, Kosugi M, Horiguchi Y, Matsumoto K, Kanai K, Suzuki E, Miyajima A, Nakagawa K, Tachibana M, Umezawa K, Oya M. Kodaira K, et al. Among authors: suzuki e. Urology. 2010 Apr;75(4):805-12. doi: 10.1016/j.urology.2009.11.048. Epub 2010 Feb 13. Urology. 2010. PMID: 20156648

6

Efficient cellular uptake of the novel NF-kappaB inhibitor (-)-DHMEQ and irreversible inhibition of NF-kappaB in neoplastic cells.

Shimada C, Ninomiya Y, Suzuki E, Umezawa K. Shimada C, et al. Among authors: suzuki e. Oncol Res. 2010;18(11-12):529-35. doi: 10.3727/096504010x12767359113721. Oncol Res. 2010. PMID: 20939428

7

Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer.

Kozakai N, Kikuchi E, Hasegawa M, Suzuki E, Ide H, Miyajima A, Horiguchi Y, Nakashima J, Umezawa K, Shigematsu N, Oya M. Kozakai N, et al. Among authors: suzuki e. Br J Cancer. 2012 Aug 7;107(4):652-7. doi: 10.1038/bjc.2012.321. Epub 2012 Jul 17. Br J Cancer. 2012. PMID: 22805327 Free PMC article.

8

Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis.

Suzuki E, Daniels TR, Helguera G, Penichet ML, Umezawa K, Bonavida B. Suzuki E, et al. Int J Oncol. 2010 May;36(5):1299-307. doi: 10.3892/ijo_00000615. Int J Oncol. 2010. PMID: 20372806 Free PMC article.

9

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer.

Ito Y, Kikuchi E, Tanaka N, Kosaka T, Suzuki E, Mizuno R, Shinojima T, Miyajima A, Umezawa K, Oya M. Ito Y, et al. Among authors: suzuki e. BMC Cancer. 2015 Apr 29;15:324. doi: 10.1186/s12885-015-1315-9. BMC Cancer. 2015. PMID: 25926105 Free PMC article.

10

Inhibition of Yin Yang 1-dependent repressor activity of DR5 transcription and expression by the novel proteasome inhibitor NPI-0052 contributes to its TRAIL-enhanced apoptosis in cancer cells.

Baritaki S, Suzuki E, Umezawa K, Spandidos DA, Berenson J, Daniels TR, Penichet ML, Jazirehi AR, Palladino M, Bonavida B. Baritaki S, et al. Among authors: suzuki e. J Immunol. 2008 May 1;180(9):6199-210. doi: 10.4049/jimmunol.180.9.6199. J Immunol. 2008. PMID: 18424742 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,829 results

Search Page

Filters